← Eichor
Study identifier: NCT07243327 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ESWT vs Conventional Physical Therapy in Greater Trochanteric Pain Syndrome

Condition: Greater Trochanteric Pain Syndrome  ·  Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study aims to compare the effectiveness of Extracorporeal Shockwave Therapy (ESWT) with conventional physical therapy in patients with Greater Trochanteric Pain Syndrome (GTPS). GTPS is a common cause of lateral hip pain, often related to gluteal tendinopathy rather than trochanteric bursitis. Sixty patients will be randomly assigned to two groups: ESWT or conventional physical therapy (TENS, hot pack, ultrasound). Pain (VAS), hip function (Harris Hip Score), lower limb function (LEFS), and global improvement will be evaluated at baseline, week 3, and week 12. The purpose of this study is to determine which treatment provides greater pain relief and functional improvement.

This description comes directly from the study's public registry record.

Talk to the study team

Zeynep Karakuzu Güngör, M.D  ·  +90 507 775 03 75  ·  zeynepkarakuzu@hotmail.com.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Kanuni Sultan Süleyman Training and Research HospitalIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07243327